Inhibition of nNOS prevents and inhibition of iNOS reverses α,β-meATP-induced facilitation of neck muscle nociception in mice

European Journal of Pharmacology

Volumn 647, Issue 1-3, 2010, Pages 55-61

  Ristic, Dejan ^a   Spangenberg, Peter ^b   Ellrich, Jens ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Brainstem; Headache; Jaw opening reflex; Nitric oxide synthase; Pain

Indexed keywords

ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; INDUCIBLE NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N(G) METHYLARGININE; N(G) PROPYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DOSE RESPONSE; ELECTROSTIMULATION; ENZYME INHIBITION; FACILITATION; HEART RATE VARIABILITY; JAW OPENING REFLEX; MALE; MOUSE; MYALGIA; NECK MUSCLE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; TENSION HEADACHE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARGININE; ENZYME INHIBITORS; IMINES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NECK MUSCLES; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NOCICEPTORS; REFLEX; TENSION-TYPE HEADACHE;

EID: 77957310863     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.08.009     Document Type: Article

References (74)

1. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 2001, 357:593-615.
2. Ashina M. Nitric oxide synthase inhibitors for the treatment of chronic tension-type headache. Expert Opin. Pharmacother. 2002, 3:395-399.
3. Ashina M. Neurobiology of chronic tension-type headache. Cephalalgia 2004, 24:161-172.
4. Ashina M. Pathophysiology of tension-type headache: potential drug targets. CNS Neurol. Disord. Drug Targets 2007, 6:238-239.
5. Ashina M., Bendtsen L., Jensen R., Lassen L.H., Sakai F., Olesen J. Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain 1999, 122:1629-1635.
6. Ashina M., Bendtsen L., Jensen R., Olesen J. Nitric oxide-induced headache in patients with chronic tension-type headache. Brain 2000, 123:1830-1837.
7. Ashina M., Bendtsen L., Jensen R., Sakai F., Olesen J. Muscle hardness in patients with chronic tension-type headache: relation to actual headache state. Pain 1999, 79:201-205.
8. Ashina M., Lassen L.H., Bendtsen L., Jensen R., Olesen J. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet 1999, 353:287-289.
9. Bendtsen L., Jensen R. Tension-type headache: the most common, but also the most neglected, headache disorder. Curr. Opin. Neurol. 2006, 19:305-309.
10. Bhat A.S., Tandan S.K., Kumar D., Krishna V., Prakash V.R. The interaction between inhibitors of nitric oxide synthase and cyclooxygenase in formalin-induced pain in mice: an isobolographic study. Anesth. Analg. 2008, 106:978-984.
11. Boettger M.K., Uceyler N., Zelenka M., Schmitt A., Reif A., Chen Y., Sommer C. Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. Eur. J. Pain 2007, 11:810-818.
12. Buchgreitz L., Lyngberg A.C., Bendtsen L., Jensen R. Increased prevalence of tension-type headache over a 12-year period is related to increased pain sensitivity. A population study. Cephalalgia 2007, 27:145-152.
13. Chiang C.Y., Dostrovsky J.O., Sessle B.J. Periaqueductal gray matter and nucleus raphe magnus involvement in anterior pretectal nucleus-induced inhibition of jaw-opening reflex in rats. Brain Res. 1991, 544:71-78.
14. Christiansen I., Iversen H., Olesen J., Tfelt-Hansen P. Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate. J. Headache Pain 2008, 9:215-220.
15. Chu Y.C., Guan Y., Skinner J., Raja S.N., Johns R.A., Tao Y.X. Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain. Pain 2005, 119:113-123.
16. Cockayne D.A., Dunn P.M., Zhong Y., Rong W., Hamilton S.G., Knight G.E., Ruan H.Z., Ma B., Yip P., Nunn P., McMahon S.B., Burnstock G., Ford A.P.D.W. P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J. Physiol. 2005, 567:621-639.
17. Coderre T.J., Yashpal K. Intracellular messengers contributing to persistent nociception and hyperalgesia induced byl-glutamate and substance-P in the rat formalin pain model. Eur. J. Neurosci. 1994, 6:1328-1334.
18. Cooper G.R., Mialkowski K., Wolff D.J. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform. Arch. Biochem. Biophys. 2000, 375:183-194.
19. Ellrich J. Electric low-frequency stimulation of the tongue induces long-term depression of the jaw-opening reflex in anesthetized mice. J. Neurophysiol. 2004, 92:3332-3338.
20. Ellrich J. Development of an experimental model for investigation of the pathophysiology of tension-type headache. Aktuelle Neurol. 2007, 34:448-451.
21. Ellrich J., Fischer A., Gilsbach J.M., Makowska A., Spangenberg P. Inhibition of nitric oxide synthases prevents and reverses a, b-meATP-induced neck muscle nociception in mice. Cephalalgia 2010, 30:1225-1232.
22. Ellrich J., Makowska A. Nerve growth factor and ATP excite different neck muscle nociceptors in anaesthetized mice. Cephalalgia 2007, 27:1226-1235.
23. Ellrich J., Messlinger K., Chiang C.Y., Hu J.W. Modulation of neuronal activity in the nucleus raphe magnus by the 5-HT(1)-receptor agonist naratriptan in rat. Pain 2001, 90:227-231.
24. Ellrich J., Wesselak M. Electrophysiology of sensory and sensorimotor processing in mice under general anesthesia. Brain Res. Brain Res. Protoc. 2003, 11:178-188.
25. Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur. J. Neurosci. 2008, 27:2783-2802.
26. Garthwaite J., Boulton C.L. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 1995, 57:683-706.
27. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B.J., Knowles R.G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 1997, 272:4959-4963.
28. Grozdanovic Z. NO message from muscle. Microsc. Res. Tech. 2001, 55:148-153.
29. Grozdanovic Z., Baumgarten H.G. Nitric oxide synthase in skeletal muscle fibers: a signaling component of the dystrophin-glycoprotein complex. Histol. Histopathol. 1999, 14:243-256.
30. Guan, Y., Yaster, M., Raja, S.N., Tao, Y.X., 2007. Genetic knockout and pharmacologic inhibition of neuronal nitric oxide synthase attenuate nerve injury-induced mechanical hypersensitivity in mice. Molecular Pain 3.
31. Haley J.E., Dickenson A.H., Schachter M. Electrophysiological evidence for a role of nitric-oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992, 31:251-258.
32. Hao J.X., Xu X.J. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors. Pain 1996, 66:313-319.
33. Iversen H.K., Holm S., Friberg L., Tfelt-Hansen P. Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate. J. Headache Pain 2008, 9:177-180.
34. Iversen H.K., Nielsen T.H., Garre K., Tfelthansen P., Olesen J. Dose-dependent headache response and dilation of limb and extracranial arteries after 3 doses of 5-isosorbide-mononitrate. Eur. J. Clin. Pharmacol. 1992, 42:31-35.
35. Iversen H.K., Olesen J. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia 1996, 16:412-418.
36. Johannes T., Mik E.G., Klingel K., Goedhart P.T., Zanke C., Nohe B., Dieterich H.J., Unertl K.E., Ince C. Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetized rats. Clin. Exp. Pharmacol. Physiol. 2009, 36:870-879.
37. Kamei J., Tamura N., Saitoh A. Possible involvement of the spinal nitric oxide/cGMP pathway in vincristine-induced painful neuropathy in mice. Pain 2005, 117:112-120.
38. Khakh B.S. Molecular physiology of P2X receptors and ATP signalling at synapses. Nat. Rev. Neurosci. 2001, 2:165-174.
39. Kidokoro Y., Kubota K., Shuto S., Sumino R. Reflex organization of masticatory muscles in the cat. J. Neurophysiol. 1968, 31:695-708.
40. Kitto K.F., Haley J.E., Wilcox G.L. Involvement of nitric-oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. 1992, 148:1-5.
41. Koulchitsky S., Fischer M.J.M., Messlinger K. Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus. Cephalalgia 2009, 29:408-417.
42. Lassen L.H., Ashina M., Christiansen I., Ulrich V., Olesen J. Nitric oxide synthase inhibition in migraine. Lancet 1997, 349:401-402.
43. Lee J.S., Zhang Y., Ro J.Y. Involvement of neuronal, inducible and endothelial nitric oxide synthases in capsaicin-induced muscle hypersensitivity. Eur. J. Pain 2009, 13:924-928.
44. Luo Z.D., Cizkova D. The role of nitric oxide in nociception. Curr. Rev. Pain 2000, 4:459-466.
45. Makowska A., Panfil C., Ellrich J. Long-term potentiation of orofacial sensorimotor processing by noxious input from the semispinal neck muscle in mice. Cephalalgia 2005, 25:109-116.
46. Makowska A., Panfil C., Ellrich J. ATP induces sustained facilitation of craniofacial nociception through P2X receptors on neck muscle nociceptors in mice. Cephalalgia 2006, 26:697-706.
47. Makowska A., Panfil C., Ellrich J. Nerve growth factor injection into semispinal neck muscle evokes sustained facilitation of the jaw-opening reflex in anesthetized mice-possible implications for tension-type headache. Exp. Neurol. 2005, 191:301-309.
48. Mao J.R., Price D.D., Zhu J.P., Lu J., Mayer D.J. The inhibition of nitric oxide-activated poly(ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. Pain 1997, 72:355-366.
49. Martucci C., Trovato A.E., Costa B., Borsani E., Franchi S., Magnaghi V., Panerai A.E., Rodella L.F., Valsecchi A.E., Sacerdote P., Colleoni M. The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1 beta, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice. Pain 2008, 137:81-95.
50. Mayer B.X., Mensik C., Krishnaswami S., Derendorf H., Eichler H.G., Schmetterer L., Wolzt M. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with l-NMMA in humans. Br. J. Clin. Pharmacol. 1999, 47:539-544.
51. Meller S.T., Cummings C.P., Traub R.J., Gebhart G.F. The role of nitric-oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 1994, 60:367-374.
52. Meller S.T., Gebhart G.F. Nitric-oxide (NO) and nociceptive processing in the spinal-cord. Pain 1993, 52:127-136.
53. Miguel T.T., Nunes-de-Souza R.L. Defensive-like behaviors and antinociception induced by NMDA injection into the periaqueductal gray of mice depend on nitric oxide synthesis. Brain Res. 2006, 1076:42-48.
54. Moncada S., Palmer R.M.J., Higgs E.A. Nitric-oxide-physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
55. Moore P.K., Oluyomi A.O., Babbedge R.C., Wallace P., Hart S.L. l-Ng-nitro arginine methyl-ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 1991, 102:198-202.
56. North R.A. P2X3 receptors and peripheral pain mechanisms. J. Physiol. 2004, 554:301-308.
57. Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol. Ther. 2008, 120:157-171.
58. Panfil C., Makowska A., Ellrich J. Brainstem and cervical spinal cord Fos immunoreactivity evoked by nerve growth factor injection into neck muscles in mice. Cephalalgia 2006, 26:128-135.
59. Reitz M., Makowska A., Ellrich J. Excitatory and inhibitory purinergic control of neck muscle nociception in anaesthetized mice. Cephalalgia 2009, 29:58-67.
60. Ristic D., Ellrich J. Involvement of NOS isoenzymes in sustained facilitation of neck muscle nociception in mice-implications for tension-type headache. Cephalalgia 2009, 29(Suppl. 1):160.
61. Rocha J.C.D., Peixoto M.E.B., Jancar S., Cunha F.D., Ribeiro R.D., da Rocha F.A.C. Dual effect of nitric oxide in articular inflammatory pain in zymosan-induced arthritis in rats. Br. J. Pharmacol. 2002, 136:588-596.
62. Sammut S., Park D.J., West A.R. Frontal cortical afferents facilitate striatal nitric oxide transmission in vivo via a NMDA receptor and neuronal NOS-dependent mechanism. J. Neurochem. 2007, 103:1145-1156.
63. Schmidtko A., Tegeder I., Geisslinger G. No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing. Trends Neurosci. 2009, 32:339-346.
64. Souslova, V., Cesare, P., Ding, Y.N., Akoplan, A.N., Stanfa, L., Suzuki, R., Carpenter, K., Nebenius-Oosthuizen, D., Smith, A.J.H., Kidd, E.J., Wood, J.N., 2001. Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X(3) (vol 407, pg 1015, 2000). Nature 409, 743-+.
65. Stovner L.J., Hagen K., Jensen R., Katsarava Z., Lipton R.B., Scher A.I., Steiner T.J., Zwart J.A. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007, 27:193-210.
66. Tambeli C.H., Parada C.A., Levine J.D., Gear R.W. Inhibition of tonic spinal glutamatergic activity induces antinociception in the rat. Eur. J. Neurosci. 2002, 16:1547-1553.
67. Tanabe M., Nagatani Y., Saitoh K., Takasu K., Ono H. Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice. Neuropharmacology 2009, 56:702-708.
68. Tang Q.B., Svensson C.I., Fitzsimmons B., Webb M., Yaksh T.L., Hua X.Y. Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation. Eur. J. Neurosci. 2007, 25:2964-2972.
69. Tsai C.M., Chiang C.Y., Yu X.M., Sessle B.J. Involvement of trigeminal subnucleus caudalis (medullary dorsal horn) in craniofacial nociceptive reflex activity. Pain 1999, 81:115-128.
70. Ulucan C., Schnell C., Messlinger K., Ellrich J. Effects of acetylsalicylic acid and morphine on neurons of the rostral ventromedial medulla in rat. Neurosci. Res. 2003, 47:391-397.
71. Wu J., Lin Q., Mcadoo D.J., Willis W.D. Nitric oxide contributes to central sensitization following intradermal injection of capsaicin. NeuroReport 1998, 9:589-592.
72. Zhang H.Q., Fast W., Marletta M.A., Martasek P., Silverman R.B. Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-l-arginine. J. Med. Chem. 1997, 40:3869-3870.
73. Zhang S., Tang J.S., Yuan B., Jia H. Electrically-evoked inhibitory effects of the nucleus submedius on the jaw-opening reflex are mediated by ventrolateral orbital cortex and periaqueductal gray matter in the rat. Neuroscience 1999, 92:867-875.
74. Zhang X.C., Zhang Y.Q., Zhao Z.Q. Involvement of nitric oxide in long-term potentiation of spinal nociceptive responses in rats. NeuroReport 2005, 16:1197-1201.